In most people, HIV can be controlled with a drug combination called HAART, short for highly active antiretroviral therapy. But HAART doesn’t wipe out the virus, and stresses on the immune system such as an infection can reactivate the latent virus and trigger its spread.
In the new study, molecular biologist Janice Clements of Johns Hopkins University in Baltimore and her colleagues infected human T cells with HIV in lab dishes, then added minocycline to some of these batches. After 24 hours, the minocycline-treated cells contained half as much HIV RNA as the other cells, suggesting the drug had inhibited the ability of the virus to replicate. The scientists also tested minocycline on T cells obtained from HIV patients who had been treated with HAART. Minocycline again stalled HIV replication, as demonstrated by a 60 percent decline in activity of a key gene that HIV needs to awaken and replicate.
To read the whole story, please CLICK THE TITLE ABOVE.
No comments:
Post a Comment